LENSAR Q4 revenue $16.0M (-4% YoY); recurring revenue up 17% to $12.7M

LENSAR, Inc.

2026-Q1 EPS reported $0.00 revenue$13,428,000

Net loss narrowed to $1.5M ($0.12/sh) from $18.7M loss a year ago, largely on warrant liability fair-value change.
Full-year revenue $58.4M (+9%); recurring revenue $46.3M (+15%) driven by 22% increase in worldwide procedures.
ALLY installed base reached ~200 systems (+48% YoY); 15 placed in Q4, 13 systems in backlog.
SG&A rose $3.5M to $10.3M, primarily from $3.5M in costs tied to the terminated Alcon merger.
Procedure volume 54,756 in Q4 (+20% YoY) and 206,014 for FY2025 (+22% YoY).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LENSAR, Inc. reported financial results for the fiscal quarter and year ended December 31, 2025.

Period: the fiscal quarter and year ended December 31, 2025
Result: reported results

Exact text from the filing

On March 31, 2026, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025.

View on SEC.gov

Browse all earnings releases →

LENSAR, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-133153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.